Vivanza Biosciences Ltd Q1 FY2023 consolidated profit at Rs. 7.42 lakhs

has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 2.3977 crores during the period ended June 30, 2022 as compared to Rs. 6.14 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.0742 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -0.20 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.19 for the period ended June 30, 2022 as compared to Rs. -0.50 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 2.3977 crs	₹6.14 crs	-60.95%
Net Profit	₹0.0742 crs	₹-0.20 crs	137.10%
EPS	₹0.19	₹-0.50	138.00%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 2.3977 crores during the period ended June 30, 2022 as compared to Rs.0.7096 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.0742 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.3218 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.19 for the period ended June 30, 2022 as compared to Rs.0.80 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 2.3977 crs	₹0.7096 crs	237.89%
Net Profit	₹0.0742 crs	₹0.3218 crs	-76.94%
EPS	₹0.19	₹0.80	-76.25%

Source : Equity Bulls

Keywords

VivanzaBiosciences Q1FY23 ResultUpdate